Infusion reactions related to infliximab therapy are not usually associated with drug discontinuation
J Rheumatol
.
2012 Aug;39(8):1500-2.
doi: 10.3899/jrheum.120649.
Authors
Garrett Cullen
,
Adam S Cheifetz
PMID:
22859528
DOI:
10.3899/jrheum.120649
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antibodies, Monoclonal / adverse effects*
Antirheumatic Agents / adverse effects*
Arthritis, Rheumatoid / drug therapy*
Female
Humans
Infliximab
Male
Substances
Antibodies, Monoclonal
Antirheumatic Agents
Infliximab